The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma

C. Pivonello, Mariarosaria Negri, Maria Cristina De Martino, Maria Napolitano, Cristina de Angelis, Donatella Paola Provvisiero, Gaia Cuomo, R. S. Auriemma, Chiara Simeoli, Francesco Izzo, A. Colao, L. J. Hofland, Rosario Pivonello

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences